Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)

被引:1
作者
Biyan Nathanael Harapan
Hyeon Joo Yoo
机构
[1] University Hospital,Department of Neurosurgery
[2] Ludwig-Maximilians-University of Munich,Department of Neuropathology
[3] Leipzig University Hospital,Department of Radiotherapy and Radiation Oncology
[4] University Hospital,Department of Neurosurgery
[5] Ludwig-Maximilians-University of Munich,undefined
[6] Heidelberg University Hospital,undefined
来源
Journal of Neurology | 2021年 / 268卷
关键词
COVID-19; SARS-CoV-2; Central nervous system; Neurological symptoms; Neurological manifestations; Neurological complications;
D O I
暂无
中图分类号
学科分类号
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is responsible for the outbreak of coronavirus disease 19 (COVID-19) and was first identified in Wuhan, China in December 2019. It is evident that the COVID-19 pandemic has become a challenging world issue. Although most COVID-19 patients primarily develop respiratory symptoms, an increasing number of neurological symptoms and manifestations associated with COVID-19 have been observed. In this narrative review, we elaborate on proposed neurotropic mechanisms and various neurological symptoms, manifestations, and complications of COVID-19 reported in the present literature. For this purpose, a review of all current published literature (studies, case reports, case series, reviews, editorials, and other articles) was conducted and neurological sequelae of COVID-19 were summarized. Essential and common neurological symptoms including gustatory and olfactory dysfunctions, myalgia, headache, altered mental status, confusion, delirium, and dizziness are presented separately in sections. Moreover, neurological manifestations and complications that are of great concern such as stroke, cerebral (sinus) venous thrombosis, seizures, meningoencephalitis, Guillain–Barré syndrome, Miller Fisher syndrome, acute myelitis, and posterior reversible encephalopathy syndrome (PRES) are also addressed systematically. Future studies that examine the impact of neurological symptoms and manifestations on the course of the disease are needed to further clarify and assess the link between neurological complications and the clinical outcome of patients with COVID-19. To limit long-term consequences, it is crucial that healthcare professionals can early detect possible neurological symptoms and are well versed in the increasingly common neurological manifestations and complications of COVID-19.
引用
收藏
页码:3059 / 3071
页数:12
相关论文
共 1169 条
[1]  
Feng W(2020)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review Mol Cancer 19 100-513
[2]  
Zong W(2020)Neurological manifestations and implications of COVID-19 pandemic Ther Adv Neurol Disord 395 507-58
[3]  
Wang F(2020)Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection Brain Behav Immun 12 e8192-3156
[4]  
Ju S(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 94 55-449
[5]  
Tsivgoulis G(2020)A review of neurological complications of COVID-19 Cureus 267 3154-702
[6]  
Palaiodimou L(2020)Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China JAMA Neurol 87 149-96
[7]  
Katsanos AH(2020)A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 Int J Infect Dis 95 445-54
[8]  
Caso V(2020)First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease J Neurol 12 e7352-370
[9]  
Köhrmann M(2020)SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis Brain Behav Immun 92 699-233
[10]  
Molina C(2020)Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid Neurology 807 75-3470